
EVAR also does not appear to be cost-effective for treatment of complicated aneurysms. Cost comparisons for
fenestrated or branched EVAR graft demonstrated higher
costs in comparison to open repair (38,212 vs 16,497)
without signiÔ¨Åcant differences in 30-day mortality.768
Most of the data for cost-effectiveness pertain to elective cases, for which expected morbidity and mortality
can be